Eating Disorders With and Without Childhood Trauma

February 21, 2020 updated by: Modum Bad

Treatment of Eating Disorders With and Without Childhood Trauma: A Randomized Controlled Trial

The combination of EDs (ED) and post-traumatic sequelae of childhood trauma leads to significant impairment, suffering and represents a public health concern because it is frequently associated with role impairment, and is frequently under-treated. Considering the severity of these conditions, there is a need to develop more effective treatments that are tailored to the specific needs of these patients as no conclusion has been made about the treatment of choice. To improve treatment it is critically important to study treatment effects and the mechanism of these effects.

Study Overview

Detailed Description

The overall aim of the current project is; (1) To build knowledge on how to best treat patients with ED with and without childhood trauma, (2) To develop our understanding about how change happens for these patients. The investigators will do this by compare two treatment models; (1) Compassion-Focused Therapy (CFT) and (2) Cognitive Behavioural Therapy (CBT), for EDs both treatment types delivered at Modum Bad Psychiatric Center, department of ED.

Patients included in this randomized controlled trial will receive treatment at Modum Bad, satisfy DSM-V criteria for ED and half of the patients will in addition have a history of childhood trauma. A total of 86 patients who have received either CFT or CBT are followed up two year after completion of the treatment. The study utilises a rich data set collected outcome measures at altogether 5 time points and process and sub-outcome measures at 13 time points. The investigators will take advantage of our established collaborative networks, both nationally and internationally and existing procedures, where all patients are assessed with the same clinical instruments based on current state-of-the-art methods.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vikersund, Norway, 3371
        • Modum Bad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • satisfying DSM-V criteria for ED and for half of the patients in addition
  • have a history of childhood trauma.

Exclusion Criteria:

  • current suicidal risk
  • current psychosis
  • ongoing trauma (e.g. current involvement in an abusive relationship).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Cognitive-Behavioural Therapy
This version of CBT is based on techniques employed in evidence-based approaches to a transdiagnostic sample. The programme includes; individualized formulation, taking into account different maintaining factors across cases (e.g., nutritional and/or emotional drivers for binging); agenda setting; homework; change in diet (particularly to improve carbohydrate intake); diary-keeping; exposure; behavioral experiments; cognitive restructuring; and surveys. The behavioral change is maintained as a focus, along with changes in mood and cognitions.
Experimental: Compassion-Focused Therapy
There are four main treatment elements to the program. Two of these are linked to the experience of being a therapy group. This involves patients providing compassionate support to other group members.The third treatment element involves compassionate mind training which mainly focuses on activating the soothing system via imagery and related practical exercises.The final element of the program aims to help patients improve their ability to use their wider social network to access support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global index from Eating Disorder Examination questionnaire
Time Frame: Pre, weekly during treatment, post, 12-months followup, through study completion, an average of 1 year
Change from baseline in eating disorder symptoms on the dimensional scales on the Eating Disorder Examination questionnaire
Pre, weekly during treatment, post, 12-months followup, through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptom checklist 90 revised
Time Frame: Time Frame: pre, post and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time Frame: pre, post and 12-months followup, through study completion, an average of 1 year
Inventory of interpersonal problems
Time Frame: Pre, post and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Pre, post and 12-months followup, through study completion, an average of 1 year
Dissociative experiences scale II
Time Frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Short form 36
Time Frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Self-compassion scale
Time Frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Symptom checklist-5
Time Frame: Pretreatment, weekly during treatment, posttreatment and 12-months followupthrough study completion, an average of 1 year
Change from baseline to 12-months follow-up
Pretreatment, weekly during treatment, posttreatment and 12-months followupthrough study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: KariAnne Vrabel, PhD, Modum Bad

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

February 1, 2020

Study Completion (Actual)

February 1, 2020

Study Registration Dates

First Submitted

September 8, 2015

First Submitted That Met QC Criteria

January 5, 2016

First Posted (Estimate)

January 7, 2016

Study Record Updates

Last Update Posted (Actual)

February 24, 2020

Last Update Submitted That Met QC Criteria

February 21, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Disorders

Clinical Trials on Cognitive-Behavioural Therapy

Subscribe